In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

NxThera closes $40mm Series D round

Executive Summary

NxThera Inc. (radiofrequency-based devices for endourological conditions including BPH) raised $40mm through what looks to be its Series D round. Boston Scientific led and was joined by returning backers Aberdare Ventures, Arboretum Ventures, GDN Holdings, and the Ally Bridge Group. The company notes that it also expanded a debt facility with East West Bank.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies